The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-(4-(3-(tert-butyldimethylsilyloxy)propyl)-3-oxopiperazine-1-carbonyl)-4-fluorobenzyl)quinazoline-2,4(1H,3H)-dione ID: ALA4569417
PubChem CID: 155560210
Max Phase: Preclinical
Molecular Formula: C29H37FN4O5Si
Molecular Weight: 568.72
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)[Si](C)(C)OCCCN1CCN(C(=O)c2cc(Cn3c(=O)[nH]c(=O)c4ccccc43)ccc2F)CC1=O
Standard InChI: InChI=1S/C29H37FN4O5Si/c1-29(2,3)40(4,5)39-16-8-13-32-14-15-33(19-25(32)35)27(37)22-17-20(11-12-23(22)30)18-34-24-10-7-6-9-21(24)26(36)31-28(34)38/h6-7,9-12,17H,8,13-16,18-19H2,1-5H3,(H,31,36,38)
Standard InChI Key: PVTGCPNFDHKZPA-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 43 0 0 0 0 0 0 0 0999 V2000
12.8893 -27.1035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3021 -27.8134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7105 -27.1010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9966 -28.9277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5922 -28.2220 0.0000 Si 0 0 0 0 0 4 0 0 0 0 0 0
12.1832 -28.9251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9879 -24.5363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9868 -25.3559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6948 -25.7648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6930 -24.1275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4016 -24.5327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4005 -25.3534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1067 -25.7624 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8186 -25.3554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8197 -24.5347 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1090 -24.1211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1090 -23.3040 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1044 -26.5796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8110 -26.9902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8073 -27.8062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5130 -28.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2229 -27.8100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2225 -26.9886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5162 -26.5818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9300 -28.2197 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.9299 -26.5795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9293 -25.7623 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5251 -25.7659 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6392 -26.9837 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6386 -27.8048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3453 -28.2136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0573 -27.8060 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0580 -26.9849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3467 -26.5716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7664 -26.5776 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7641 -28.2161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4727 -27.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1795 -28.2193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8881 -27.8123 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0094 -28.2271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
5 4 1 0
6 5 1 0
7 8 2 0
8 9 1 0
9 12 2 0
11 10 2 0
10 7 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
13 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
23 26 1 0
26 29 1 0
26 27 2 0
14 28 2 0
29 30 1 0
29 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
33 35 2 0
32 36 1 0
36 37 1 0
37 38 1 0
38 39 1 0
39 5 1 0
5 2 1 0
2 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 568.72Molecular Weight (Monoisotopic): 568.2517AlogP: ┄#Rotatable Bonds: ┄Polar Surface Area: ┄Molecular Species: ┄HBA: ┄HBD: ┄#RO5 Violations: ┄HBA (Lipinski): ┄HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: ┄CX LogD: ┄Aromatic Rings: ┄Heavy Atoms: ┄QED Weighted: ┄Np Likeness Score: ┄
References 1. Jain PG, Patel BD.. (2019) Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update., 165 [PMID:30684797 ] [10.1016/j.ejmech.2019.01.024 ] 2. Wang YQ, Wang PY, Wang YT, Yang GF, Zhang A, Miao ZH.. (2016) An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy., 59 (21): [PMID:27416328 ] [10.1021/acs.jmedchem.6b00055 ]